Unique Plan Description: OB Hemorrhage Meds (FH)
Plan Selection Display: OB Hemorrhage Meds (FH)
PlanType: Medical                                 
Version: 1          
Begin Effective Date: 2020-04-21 19:21:00
End Effective Date: 2100-12-31 00:00:00
Last Updated Date: 2024-12-31 10:06:37
Available at all facilities: Yes

OB Hemorrhage Meds (FH)
Laboratory
	Type and Screen (No Product on hold)
		Routine, spec type = Blood
Medications
	Cytotec
		800 mcg, Tab, RECTALLY, Once, PRN, bleeding
	Methergine
		0.2 mg, Injection, IM-IntraMUSCULAR, Q2H, PRN, uterine relaxation
			Comment: Avoid in hypertensive patients
	Hemabate
		250 mcg, Injection, IM-IntraMUSCULAR, Q15MIN, PRN, uterine relaxation, 8 Dose(s)/Time(s)
			Comment: Avoid in asthmatic patients.  Relative contraindication if hepatic, renal and cardiac disease
	tranexamic acid
		1,000 mg, Solution, IV Push, Once, PRN for see comment
			Comment: Hemorrhage management, push slowly over 10 minutes to avoid hypotension.
	oxytocin 30 units/500mL Premix IV
		500 mL, IV, Routine, T;N
			Comment: infuse 15 units over 15 minutes (999ml/hr), if firm uterine tone present, change rate to 15 units over 3 hours (83.3ml/hr)
		30 units, EVERY BAG

*Report Legend:
DEF - This order sentence is the default for the selected order
GOAL - This component is a goal
IND - This component is an indicator
INT - This component is an intervention
IVS - This component is an IV Set
NOTE - This component is a note
Rx - This component is a prescription
SUB - This component is a sub phase